דינמיקת הכנסות משנה לשנה ב-12 החודשים האחרונים: Purple Biotech (PPBT)

Purple Biotech is a biotech developer of targeted therapies leveraging partnerships with leading oncology centers and the test results of CM24 and NT219. The company focuses on overcoming tumor immunity defenses when treating resistant forms of cancer. Successful clinical phases of its pancreatic inhibitor and patent protection create potential for M&A. The revenue trend over four quarters compared to the same period last year demonstrates income dynamics, where 0.00 captures a new level.
Purple Biotech Ltd. - פילוחים אנליטיים ומדדי מפתח (PPBT)

To assess the credit quality of Purple Biotech (PPBT), the analyst examines cash flow dynamics, where the annual growth in sales volumes over a rolling four-quarter period reflects the rate of revenue expansion relative to the previous year. A positive trend in this indicator confirms the commercial success of the company's diversified strategy to develop combination drugs for the therapy of resistant tumors, signaling growing market demand for its oncological developments.